MyAverix Finance
US · Healthcare
Mainz Biomed BV (MYNZ)
Diagnostics & Research
Mainz Biomed BV (MYNZ) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MYNZ
Mainz Biomed BV (MYNZ) — FAQ
What is MYNZ's P/E ratio?
The price-to-earnings (P/E) ratio for Mainz Biomed BV (MYNZ) is 18.00 (data as of 2026-05-23).
Does Mainz Biomed BV pay a dividend?
Dividend yield is not available in the current snapshot for Mainz Biomed BV (MYNZ). Check the MyAverix Finance app for the latest dividend data.
What sector is Mainz Biomed BV in?
Mainz Biomed BV (MYNZ) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is MYNZ listed on?
MYNZ is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.